Sjöström CD - Search Results

1

Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease.

Dekkers CCJ, Wheeler DC, Sjöström CD, Stefansson BV, Cain V, Heerspink HJL. Dekkers CCJ, et al. Among authors: sjostrom cd. Nephrol Dial Transplant. 2018 Nov 1;33(11):2005-2011. doi: 10.1093/ndt/gfx350. Nephrol Dial Transplant. 2018. PMID: 29370424 Free PMC article.

2

Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin.

Grandy S, Hashemi M, Langkilde AM, Parikh S, Sjöström CD. Grandy S, et al. Among authors: sjostrom cd. Diabetes Obes Metab. 2014 Jul;16(7):645-50. doi: 10.1111/dom.12263. Epub 2014 Feb 9. Diabetes Obes Metab. 2014. PMID: 24443876 Clinical Trial.

3

Grandy S, Langkilde AM, Sugg JE, Parikh S, Sjöström CD. Grandy S, et al. Among authors: sjostrom cd. Int J Clin Pract. 2014 Apr;68(4):486-94. doi: 10.1111/ijcp.12341. Epub 2014 Feb 6. Int J Clin Pract. 2014. PMID: 24499168 Clinical Trial.

4

Dapagliflozin-induced weight loss affects 24-week glycated haemoglobin and blood pressure levels.

Sjöström CD, Hashemi M, Sugg J, Ptaszynska A, Johnsson E. Sjöström CD, et al. Diabetes Obes Metab. 2015 Aug;17(8):809-12. doi: 10.1111/dom.12500. Epub 2015 Jun 27. Diabetes Obes Metab. 2015. PMID: 25997813

5

Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes.

Sjöström CD, Johansson P, Ptaszynska A, List J, Johnsson E. Sjöström CD, et al. Diab Vasc Dis Res. 2015 Sep;12(5):352-8. doi: 10.1177/1479164115585298. Epub 2015 May 25. Diab Vasc Dis Res. 2015. PMID: 26008804 Free article.

6

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers.

Heerspink HJ, Johnsson E, Gause-Nilsson I, Cain VA, Sjöström CD. Heerspink HJ, et al. Among authors: sjostrom cd. Diabetes Obes Metab. 2016 Jun;18(6):590-7. doi: 10.1111/dom.12654. Diabetes Obes Metab. 2016. PMID: 26936519 Free PMC article. Clinical Trial.

7

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment.

Fioretto P, Stefansson BV, Johnsson E, Cain VA, Sjöström CD. Fioretto P, et al. Among authors: sjostrom cd. Diabetologia. 2016 Sep;59(9):2036-9. doi: 10.1007/s00125-016-4017-1. Epub 2016 Jun 15. Diabetologia. 2016. PMID: 27306615 Free PMC article. Clinical Trial. No abstract available.

8

Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.

Lundkvist P, Sjöström CD, Amini S, Pereira MJ, Johnsson E, Eriksson JW. Lundkvist P, et al. Among authors: sjostrom cd. Diabetes Obes Metab. 2017 Jan;19(1):49-60. doi: 10.1111/dom.12779. Epub 2016 Sep 26. Diabetes Obes Metab. 2017. PMID: 27550386 Free PMC article. Clinical Trial.

9

Efficacy and safety of dapagliflozin in Asian patients: A pooled analysis.

Yang W, Ji L, Zhou Z, Cain VA, Johnsson KM, Sjöström CD. Yang W, et al. Among authors: sjostrom cd. J Diabetes. 2017 Aug;9(8):787-799. doi: 10.1111/1753-0407.12484. Epub 2016 Nov 14. J Diabetes. 2017. PMID: 27625142 Clinical Trial.

10

Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function.

Petrykiv S, Sjöström CD, Greasley PJ, Xu J, Persson F, Heerspink HJL. Petrykiv S, et al. Among authors: sjostrom cd. Clin J Am Soc Nephrol. 2017 May 8;12(5):751-759. doi: 10.2215/CJN.10180916. Epub 2017 Mar 16. Clin J Am Soc Nephrol. 2017. PMID: 28302903 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters